<DOC>
	<DOCNO>NCT00321165</DOCNO>
	<brief_summary>Total parenteral ( intravenous ) nutrition home setting ( Home TPN HPN ) life save strategy patient suffer severe intestinal failure . Unfortunately , treatment modality remain complicated development frequent infectious complication . This especially relate device use establish venous access , mostly catheter ( Hickman-Broviac type ) port-a-cath . Taurolodine antimicrobial agent without know side effect resistance-related problem hold promise effective antibiotic lock solution prevent catheter infection , demonstrate recently pilot study HPN patient [ Jurewitsch , 2005 ] . In addition , recently test described may enable confirm suspect diagnosis central line infection within one hour , so-called Acridine Orange Leukocyte Cytospin test ( AOLC ) [ Bong , 2003 ] . For test , blood drawn central line stain fluorescent dye acridine orange . Next , microscopic evaluation presence micro-organisms take place . Implementation test might enable start treatment infection prevent unnecessary removal non-infected central line without necessity several day wait culture result .</brief_summary>
	<brief_title>The AOT ( Acridine Orange Taurolidine ) Trial</brief_title>
	<detailed_description>Two hypothesis test AOT trial : 1 . The use taurolidine antibiotic lock ( 5 mL ) flush central line infuse TPN formulation , compare present use heparin solution ( 5 mL , 150 E/mL ) decrease rate catheter-related infection HPN patient 2 . Implementation acridine orange stain test allow early diagnosis ( rejection diagnosis ) compare culture result . Importantly , present trial result test use treatment decision . To end , patient admit clinical ward suspect central line infection ( mostly fever and/or chill ) treat accord current protocol catheter sepsis , obtain central line peripheral blood culture . This protocol include administration medicinase central line i.v . antibiotic peripherally . After obtain informed consent , addition 5 cc EDTA blood drawn central line perform ( within 24 hour ) acridine orange cytospin stain test Gram stain . These result compare culture result . Based culture result , antibiotic tailor . If patient recovers TPN administration restart , randomisation heparin lock ( 5 mL , 150 E/mL ) versus taurolidine lock solution 2 % ( 5 mL ) take place . In case catheter remove ongoing recurrent sepsis , randomisation take place new central line place patient continue TPN . A new episode prove catheter sepsis consider primary end-point .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Catheter-Related Infections</mesh_term>
	<mesh_term>Taurolidine</mesh_term>
	<criteria>informed consent patient home TPN central line ( Hickman Porthacath ) suspect central line infection ( acridine orange test ) proven central line infection ( randomisation tauroline v heparin ) inform consent patient home TPN arteriovenous fistula ( shunt )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>nutrition</keyword>
	<keyword>parenteral</keyword>
	<keyword>infection</keyword>
	<keyword>katheter</keyword>
	<keyword>taurolidine</keyword>
	<keyword>acridine orange</keyword>
	<keyword>prevention</keyword>
</DOC>